Chinese Traditional Medicine Stocks Surge; Jinghua Pharmaceutical and Sanli Pharmaceutical Hit Limit Up

A broad TCM rally without a named catalyst is a sentiment move, not a fundamentals story — the kind of session that often reflects sector rotation or policy anticipation rather than company-level news. The limit-up pairing of Jinghua and Sanli matters because it sets the tone for smaller names like Qianjin, Wohua, Datang and Shengligu, which tend to trade as a sympathy block. Whether the move holds once a catalyst is identified, or fades as an unexplained spike, is the open question.